Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 1,599 shares at $119.36 ($190K) on 2019-04-15, disclosed to the SEC on 2019-04-17.
Open-market sale of $190k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.96 | 100 | $12K | 6.1% |
| 2 | $118.88 | 301 | $36K | 18.8% |
| 3 | $119.36 | 599 | $71K | 37.5% |
| 4 | $119.36 | 599 | $71K | 37.5% |
| Total | $119.12 avg | 1,599 | $190K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |